Global Drug-Eluting Stent Market Growth 2022-2028

Publication Month: Feb 2022 | No. of Pages: 117 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

As the global economy mends, the 2021 growth of Drug-Eluting Stent will have significant change from previous year. According to our (LP Information) latest study, the global Drug-Eluting Stent market size is USD million in 2022 from USD 5824.5 million in 2021, with a change of % between 2021 and 2022. The global Drug-Eluting Stent market size will reach USD 7476.2 million in 2028, growing at a CAGR of 3.6% over the analysis period.
The United States Drug-Eluting Stent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug-Eluting Stent market, reaching US$ million by the year 2028. As for the Europe Drug-Eluting Stent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug-Eluting Stent players cover Boston Scientific, Medtronic, Abbott, and Lepu Medical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Rapamycin Eluting Stent
Paclitaxel Eluting Stent
Everolimus Eluting Stent
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boston Scientific
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Eluting Stent Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug-Eluting Stent by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug-Eluting Stent by Country/Region, 2017, 2022 & 2028
2.2 Drug-Eluting Stent Segment by Type
2.2.1 Rapamycin Eluting Stent
2.2.2 Paclitaxel Eluting Stent
2.2.3 Everolimus Eluting Stent
2.2.4 Others
2.3 Drug-Eluting Stent Sales by Type
2.3.1 Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)
2.3.2 Global Drug-Eluting Stent Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drug-Eluting Stent Sale Price by Type (2017-2022)
2.4 Drug-Eluting Stent Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug-Eluting Stent Sales by Application
2.5.1 Global Drug-Eluting Stent Sale Market Share by Application (2017-2022)
2.5.2 Global Drug-Eluting Stent Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug-Eluting Stent Sale Price by Application (2017-2022)
3 Global Drug-Eluting Stent by Company
3.1 Global Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Drug-Eluting Stent Annual Sales by Company (2020-2022)
3.1.2 Global Drug-Eluting Stent Sales Market Share by Company (2020-2022)
3.2 Global Drug-Eluting Stent Annual Revenue by Company (2020-2022)
3.2.1 Global Drug-Eluting Stent Revenue by Company (2020-2022)
3.2.2 Global Drug-Eluting Stent Revenue Market Share by Company (2020-2022)
3.3 Global Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Stent Product Location Distribution
3.4.2 Players Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drug-Eluting Stent by Geographic Region
4.1 World Historic Drug-Eluting Stent Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug-Eluting Stent Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug-Eluting Stent Annual Revenue by Geographic Region
4.2 World Historic Drug-Eluting Stent Market Size by Country/Region (2017-2022)
4.2.1 Global Drug-Eluting Stent Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug-Eluting Stent Annual Revenue by Country/Region
4.3 Americas Drug-Eluting Stent Sales Growth
4.4 APAC Drug-Eluting Stent Sales Growth
4.5 Europe Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Drug-Eluting Stent Sales Growth
5 Americas
5.1 Americas Drug-Eluting Stent Sales by Country
5.1.1 Americas Drug-Eluting Stent Sales by Country (2017-2022)
5.1.2 Americas Drug-Eluting Stent Revenue by Country (2017-2022)
5.2 Americas Drug-Eluting Stent Sales by Type
5.3 Americas Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Stent Sales by Region
6.1.1 APAC Drug-Eluting Stent Sales by Region (2017-2022)
6.1.2 APAC Drug-Eluting Stent Revenue by Region (2017-2022)
6.2 APAC Drug-Eluting Stent Sales by Type
6.3 APAC Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug-Eluting Stent by Country
7.1.1 Europe Drug-Eluting Stent Sales by Country (2017-2022)
7.1.2 Europe Drug-Eluting Stent Revenue by Country (2017-2022)
7.2 Europe Drug-Eluting Stent Sales by Type
7.3 Europe Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Drug-Eluting Stent Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug-Eluting Stent Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Drug-Eluting Stent
10.4 Industry Chain Structure of Drug-Eluting Stent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Stent Distributors
11.3 Drug-Eluting Stent Customer
12 World Forecast Review for Drug-Eluting Stent by Geographic Region
12.1 Global Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Drug-Eluting Stent Forecast by Region (2023-2028)
12.1.2 Global Drug-Eluting Stent Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Eluting Stent Forecast by Type
12.7 Global Drug-Eluting Stent Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug-Eluting Stent Product Offered
13.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug-Eluting Stent Product Offered
13.2.3 Medtronic Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug-Eluting Stent Product Offered
13.3.3 Abbott Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug-Eluting Stent Product Offered
13.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 B. Braun Melsungen
13.5.1 B. Braun Melsungen Company Information
13.5.2 B. Braun Melsungen Drug-Eluting Stent Product Offered
13.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 B. Braun Melsungen Main Business Overview
13.5.5 B. Braun Melsungen Latest Developments
13.6 MicroPort Scientific
13.6.1 MicroPort Scientific Company Information
13.6.2 MicroPort Scientific Drug-Eluting Stent Product Offered
13.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 MicroPort Scientific Main Business Overview
13.6.5 MicroPort Scientific Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Drug-Eluting Stent Product Offered
13.7.3 Cook Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Drug-Eluting Stent Product Offered
13.8.3 Terumo Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Drug-Eluting Stent Product Offered
13.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Balton
13.10.1 Balton Company Information
13.10.2 Balton Drug-Eluting Stent Product Offered
13.10.3 Balton Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Balton Main Business Overview
13.10.5 Balton Latest Developments
13.11 AlviMedica Medical Technologies
13.11.1 AlviMedica Medical Technologies Company Information
13.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Product Offered
13.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AlviMedica Medical Technologies Main Business Overview
13.11.5 AlviMedica Medical Technologies Latest Developments
13.12 Biotronik
13.12.1 Biotronik Company Information
13.12.2 Biotronik Drug-Eluting Stent Product Offered
13.12.3 Biotronik Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biotronik Main Business Overview
13.12.5 Biotronik Latest Developments
13.13 Shandong JW Medical
13.13.1 Shandong JW Medical Company Information
13.13.2 Shandong JW Medical Drug-Eluting Stent Product Offered
13.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shandong JW Medical Main Business Overview
13.13.5 Shandong JW Medical Latest Developments
13.14 Sino Medical
13.14.1 Sino Medical Company Information
13.14.2 Sino Medical Drug-Eluting Stent Product Offered
13.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sino Medical Main Business Overview
13.14.5 Sino Medical Latest Developments
13.15 Beijing AMSINO
13.15.1 Beijing AMSINO Company Information
13.15.2 Beijing AMSINO Drug-Eluting Stent Product Offered
13.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Beijing AMSINO Main Business Overview
13.15.5 Beijing AMSINO Latest Developments
14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug-Eluting Stent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rapamycin Eluting Stent
Table 4. Major Players of Paclitaxel Eluting Stent
Table 5. Major Players of Everolimus Eluting Stent
Table 6. Major Players of Others
Table 7. Global Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 8. Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 9. Global Drug-Eluting Stent Revenue by Type (2017-2022) & ($ million)
Table 10. Global Drug-Eluting Stent Revenue Market Share by Type (2017-2022)
Table 11. Global Drug-Eluting Stent Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
Table 13. Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 14. Global Drug-Eluting Stent Revenue by Application (2017-2022)
Table 15. Global Drug-Eluting Stent Revenue Market Share by Application (2017-2022)
Table 16. Global Drug-Eluting Stent Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Drug-Eluting Stent Sales by Company (2020-2022) & (K Units)
Table 18. Global Drug-Eluting Stent Sales Market Share by Company (2020-2022)
Table 19. Global Drug-Eluting Stent Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Drug-Eluting Stent Revenue Market Share by Company (2020-2022)
Table 21. Global Drug-Eluting Stent Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 23. Players Drug-Eluting Stent Products Offered
Table 24. Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug-Eluting Stent Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Drug-Eluting Stent Sales Market Share Geographic Region (2017-2022)
Table 29. Global Drug-Eluting Stent Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Drug-Eluting Stent Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Drug-Eluting Stent Sales Market Share by Country/Region (2017-2022)
Table 33. Global Drug-Eluting Stent Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Drug-Eluting Stent Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 36. Americas Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 37. Americas Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 39. Americas Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 40. Americas Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 41. Americas Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
Table 42. Americas Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 43. APAC Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)
Table 44. APAC Drug-Eluting Stent Sales Market Share by Region (2017-2022)
Table 45. APAC Drug-Eluting Stent Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Drug-Eluting Stent Revenue Market Share by Region (2017-2022)
Table 47. APAC Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 48. APAC Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 49. APAC Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
Table 50. APAC Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 51. Europe Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 52. Europe Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 53. Europe Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 55. Europe Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 56. Europe Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 57. Europe Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
Table 58. Europe Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Drug-Eluting Stent Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Drug-Eluting Stent
Table 68. Key Market Challenges & Risks of Drug-Eluting Stent
Table 69. Key Industry Trends of Drug-Eluting Stent
Table 70. Drug-Eluting Stent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drug-Eluting Stent Distributors List
Table 73. Drug-Eluting Stent Customer List
Table 74. Global Drug-Eluting Stent Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Drug-Eluting Stent Sales Market Forecast by Region
Table 76. Global Drug-Eluting Stent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Drug-Eluting Stent Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Drug-Eluting Stent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Drug-Eluting Stent Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Drug-Eluting Stent Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Drug-Eluting Stent Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Drug-Eluting Stent Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2023-2028)
Table 94. Boston Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Drug-Eluting Stent Product Offered
Table 96. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. Medtronic Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. Medtronic Drug-Eluting Stent Product Offered
Table 101. Medtronic Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Medtronic Main Business
Table 103. Medtronic Latest Developments
Table 104. Abbott Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Drug-Eluting Stent Product Offered
Table 106. Abbott Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Abbott Main Business
Table 108. Abbott Latest Developments
Table 109. Lepu Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. Lepu Medical Drug-Eluting Stent Product Offered
Table 111. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Lepu Medical Main Business
Table 113. Lepu Medical Latest Developments
Table 114. B. Braun Melsungen Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. B. Braun Melsungen Drug-Eluting Stent Product Offered
Table 116. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. B. Braun Melsungen Main Business
Table 118. B. Braun Melsungen Latest Developments
Table 119. MicroPort Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. MicroPort Scientific Drug-Eluting Stent Product Offered
Table 121. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. MicroPort Scientific Main Business
Table 123. MicroPort Scientific Latest Developments
Table 124. Cook Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. Cook Medical Drug-Eluting Stent Product Offered
Table 126. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Cook Medical Main Business
Table 128. Cook Medical Latest Developments
Table 129. Terumo Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Terumo Drug-Eluting Stent Product Offered
Table 131. Terumo Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Terumo Main Business
Table 133. Terumo Latest Developments
Table 134. Biosensors International Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 135. Biosensors International Drug-Eluting Stent Product Offered
Table 136. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Biosensors International Main Business
Table 138. Biosensors International Latest Developments
Table 139. Balton Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 140. Balton Drug-Eluting Stent Product Offered
Table 141. Balton Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Balton Main Business
Table 143. Balton Latest Developments
Table 144. AlviMedica Medical Technologies Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 145. AlviMedica Medical Technologies Drug-Eluting Stent Product Offered
Table 146. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. AlviMedica Medical Technologies Main Business
Table 148. AlviMedica Medical Technologies Latest Developments
Table 149. Biotronik Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 150. Biotronik Drug-Eluting Stent Product Offered
Table 151. Biotronik Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Biotronik Main Business
Table 153. Biotronik Latest Developments
Table 154. Shandong JW Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 155. Shandong JW Medical Drug-Eluting Stent Product Offered
Table 156. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 157. Shandong JW Medical Main Business
Table 158. Shandong JW Medical Latest Developments
Table 159. Sino Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 160. Sino Medical Drug-Eluting Stent Product Offered
Table 161. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 162. Sino Medical Main Business
Table 163. Sino Medical Latest Developments
Table 164. Beijing AMSINO Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 165. Beijing AMSINO Drug-Eluting Stent Product Offered
Table 166. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 167. Beijing AMSINO Main Business
Table 168. Beijing AMSINO Latest Developments
List of Figures
Figure 1. Picture of Drug-Eluting Stent
Figure 2. Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Stent Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug-Eluting Stent Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug-Eluting Stent Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rapamycin Eluting Stent
Figure 10. Product Picture of Paclitaxel Eluting Stent
Figure 11. Product Picture of Everolimus Eluting Stent
Figure 12. Product Picture of Others
Figure 13. Global Drug-Eluting Stent Sales Market Share by Type in 2021
Figure 14. Global Drug-Eluting Stent Revenue Market Share by Type (2017-2022)
Figure 15. Drug-Eluting Stent Consumed in Hospitals
Figure 16. Global Drug-Eluting Stent Market: Hospitals (2017-2022) & (K Units)
Figure 17. Drug-Eluting Stent Consumed in Clinics
Figure 18. Global Drug-Eluting Stent Market: Clinics (2017-2022) & (K Units)
Figure 19. Drug-Eluting Stent Consumed in Ambulatory Surgical Centers
Figure 20. Global Drug-Eluting Stent Market: Ambulatory Surgical Centers (2017-2022) & (K Units)
Figure 21. Drug-Eluting Stent Consumed in Others
Figure 22. Global Drug-Eluting Stent Market: Others (2017-2022) & (K Units)
Figure 23. Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)
Figure 24. Global Drug-Eluting Stent Revenue Market Share by Application in 2021
Figure 25. Drug-Eluting Stent Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Drug-Eluting Stent Revenue Market Share by Company in 2021
Figure 27. Global Drug-Eluting Stent Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Drug-Eluting Stent Revenue Market Share by Geographic Region in 2021
Figure 29. Global Drug-Eluting Stent Sales Market Share by Region (2017-2022)
Figure 30. Global Drug-Eluting Stent Revenue Market Share by Country/Region in 2021
Figure 31. Americas Drug-Eluting Stent Sales 2017-2022 (K Units)
Figure 32. Americas Drug-Eluting Stent Revenue 2017-2022 ($ Millions)
Figure 33. APAC Drug-Eluting Stent Sales 2017-2022 (K Units)
Figure 34. APAC Drug-Eluting Stent Revenue 2017-2022 ($ Millions)
Figure 35. Europe Drug-Eluting Stent Sales 2017-2022 (K Units)
Figure 36. Europe Drug-Eluting Stent Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Drug-Eluting Stent Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Drug-Eluting Stent Revenue 2017-2022 ($ Millions)
Figure 39. Americas Drug-Eluting Stent Sales Market Share by Country in 2021
Figure 40. Americas Drug-Eluting Stent Revenue Market Share by Country in 2021
Figure 41. United States Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Drug-Eluting Stent Sales Market Share by Region in 2021
Figure 46. APAC Drug-Eluting Stent Revenue Market Share by Regions in 2021
Figure 47. China Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Drug-Eluting Stent Sales Market Share by Country in 2021
Figure 54. Europe Drug-Eluting Stent Revenue Market Share by Country in 2021
Figure 55. Germany Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country in 2021
Figure 62. Egypt Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2021
Figure 68. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 69. Industry Chain Structure of Drug-Eluting Stent
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets